Maria Hörnberg is now the new Product Manager at InfiCure Bio. Maria has a PhD in Molecular Biology and prior to her position at InfiCure Bio she was the coordinator of the Transgene Core Facility at Umeå University. We are very happy to have her on board!
InfiCure Bio was awarded Innovative Start up Phase II from Vinnova. This opens up an additional market segment for InfiCure Bio, since the grant will fund the validation of the N-IF and the NFL strains as models for NASH. Read more about the granted project at https://www.vinnova.se/p/validering-av-nya-djurmodeller-for-effekttester-av-substanser-for-behandling-av-fettlever/
InfiCure Bio is one of the sponsors of Anti-Fibrotic Drug Development Summit (AFDD) at Hyatt Regency in Boston. The AFDD brings together important experts in different areas of drug development with the aim to find better solutions and faster development of drugs to treat fibrosis.
Our application to Horizon 2020 SME Phase I was granted! Read about our project in the Horizon 2020 SME Instrument data hub.
PartnerInvest Norr and Nordic Light Capital are local investors investing in InfiCure Bio. This is a great opportunity for InfiCure which makes it possible for the company to go global and expand its business. Read more about inte investment: https://affarsliv24.vk.se/2107674/riskkapital-till-umeaforetag-stor-global-potential
InfiCure Bio is present at NLSDays 2017 in Malmö on September 13th-14th. Take the chance to come and talk to us about our amazing N-IF model and other models currently in our pipeline. NLSDays is an excellent place to discuss new and emerging life science questions and as you know, we have fibrosis in focus.
InfiCure Bio was one of eight Nordic companies presenting at the 29th Seed Forum in New York on Wednesday June 7th. Last Minute Brief was held at Nordic Innovation House, WeWork Grand Central, on Tuesday June 6ht and a group picture was taken at Lexington Ave. The 29th Seed Forum had a great interest from numerous [...]
InfiCure Bio is one of 9 Nordic companies which will meet with American investors in New York on 7th of June. The three Swedish companies are InfiCure Bio, Smartster and Poseidon. Yesterday, the Swedish companies met at Carnegie Investment Bank to present their investor pitches and get feed-back from Björn Jansson, CEO of Carnegie, and Viktor Lindberg, Analyst [...]
InfiCure Bio is awarded Connect Company of 2016 in northern Sweden. There were 26 companies in the competition and the winner was announced at the annual meeting of Connect Norr. The company will besides the honor of being the winner be present at the largest investment meeting in Sweden - Connect2Capital 2018 in Gothenburg.
InfiCure Bio was selected as 2016 Connect Company in Västerbotten at the annual meeting of Connect in Umeå. Five companies were nominated for the prize and the winner was chosen by the Board of Connect Sweden. InfiCure Bio is now nominated to compete for the title 2016 Connect Company in northern Sweden. Read more about the event [...]